The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2017

Filed:

Oct. 02, 2014
Applicant:

Viventia Bio, Inc., Winnipeg, CA;

Inventors:

Jeannick Cizeau, Winnipeg, CA;

Arjune Premsukh, Winnipeg, CA;

Shilpa Chooniedass, Winnipeg, CA;

Glen MacDonald, Winnipeg, CA;

Joycelyn Entwistle, Winnipeg, CA;

Assignee:

VIVENTIA BIO INC., Winnipeg, Manitoba, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); G01N 33/574 (2006.01); A61K 47/48 (2006.01); A61K 49/00 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/48438 (2013.01); A61K 47/48446 (2013.01); A61K 47/48484 (2013.01); A61K 47/48569 (2013.01); A61K 49/0002 (2013.01); G01N 33/574 (2013.01); C07K 2317/24 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/92 (2013.01); C07K 2319/55 (2013.01);
Abstract

The present disclosure is related to compositions of antibodies and immunoconjugates that potentially lack T-cell epitopes and elicit reduced immune response. The antibody may be an antibody fragment, such as Fab, Fab', F(ab′)2, scFv, dsFv, ds-scFv, dimers, minibodies, diabodies, bispecific antibody fragments, multimers, and any combination thereof. In a further embodiment, the antibody may bind to an antigen epithelial cell adhesion molecule (EpCAM). In another embodiment, an immunoconjugate may comprise an antibody attached to an effector molecule, wherein the effector molecule may be a radioisotope, an antineoplastic agent, an immunomodulator, a biological response modifier, lectin, a toxin, a chromophore, a fluorophore, a chemiluminescent compound, an enzyme, a metal ion, and any combination thereof.


Find Patent Forward Citations

Loading…